Edwards; Wilson

Patent Applications and Registrations

Patent applications and USPTO patent grants for Edwards; Wilson.The latest application filed is for "immunopet and immunospect imaging to identify cytotoxic t cell activity".

Company Profile

17.9.19

Edwards; Wilson - Columbia MO
Edwards; Wilson - Cardiff-by the-Sea CA
Edwards; Wilson - Cardiff by the Sea CA
Edwards; Wilson - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Immunopet And Immunospect Imaging To Identify Cytotoxic T Cell Activity App 20220296737 - Anderson; Carolyn ; et al.	2022-09-22
Immunoglobulins and uses thereof Grant 11,401,315 - Macielag , et al. August 2, 2	2022-08-02
Antibodies to Pyroglutamate Amyloid-B and Uses Thereof App 20220177560 - Van Broeck; Bianca ; et al.	2022-06-09
Antibodies To Pyroglutamate Amyloid-b And Uses Thereof App 20220106387 - Van Broeck; Bianca ; et al.	2022-04-07
Anti-idiotypic Antibodies Against Anti-klk2 Antibodies App 20220064334 - AINEKULU; Zemeda ; et al.	2022-03-03
Anti-idiotypic Antibodies Against Anti-gprc5d Antibodies App 20220064284 - CHI; Ellen ; et al.	2022-03-03
Antibodies to pyroglutamate amyloid-.beta. and uses thereof Grant 11,236,155 - Van Broeck , et al. February 1, 2	2022-02-01
Glucagon Like Peptide 1 (glp-1) Fusion Peptide Coupled Cyclic Peptide Tyrosine Tyrosine Conjugates And Uses Thereof App 20210253661 - ZHANG; Yue-Mei ; et al.	2021-08-19
Antibody-Coupled Cyclic Peptide Tyrosine Tyrosine Compounds as Modulators of Neuropeptide Y Receptors App 20210163566 - MACIELAG; Mark ; et al.	2021-06-03
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors Grant 10,968,265 - Macielag , et al. April 6, 2	2021-04-06
Immunoglobulins And Uses Thereof App 20210094998 - MACIELAG; Mark ; et al.	2021-04-01
Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof Grant 10,875,902 - Zhang , et al. December 29, 2	2020-12-29
Immunoglobulins And Uses Thereof App 20200385439 - MACIELAG; Mark ; et al.	2020-12-10
Immunoglobulins and uses thereof Grant 10,858,413 - Macielag , et al. December 8, 2	2020-12-08
Antibodies to Pyroglutamate Amyloid-B and Uses Thereof App 20200308261 - Van Broeck; Bianca ; et al.	2020-10-01
Immunoglobulins and uses thereof Grant 10,787,495 - Macielag , et al. September 29, 2	2020-09-29
Antibody-coupled Cyclic Peptide Tyrosine Tyrosine Compounds As Modulators Of Neuropeptide Y Receptors App 20200283491 - MACIELAG; Mark ; et al.	2020-09-10
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors Grant 10,640,544 - Macielag , et al.	2020-05-05
Immunoglobulins And Uses Thereof App 20190367577 - MACIELAG; Mark ; et al.	2019-12-05
Glucagon Like Peptide 1 (glp-1) Fusion Peptide Coupled Cyclic Peptide Tyrosine Tyrosine Conjugates And Uses Thereof App 20190330296 - ZHANG; Yue-Mei ; et al.	2019-10-31
Antibody-coupled Cyclic Peptide Tyrosine Tyrosine Compounds As Modulators Of Neuropeptide Y Receptors App 20190298849 - MACIELAG; Mark ; et al.	2019-10-03
Immunoglobulins and uses thereof Grant 10,428,134 - Macielag , et al. October 1, 2	2019-10-01
Immunoglobulins And Uses Thereof App 20190263879 - MACIELAG; Mark ; et al.	2019-08-29
Kv1.3 Antagonists and Methods of Use App 20190062383 - Chi; Ellen ; et al.	2019-02-28
Kv1.3 antagonists and methods of use Grant 10,179,808 - Chi , et al. Ja	2019-01-15
Immunoglobulins And Uses Thereof App 20180125998 - Macielag; Mark ; et al.	2018-05-10
Antibody-coupled Cyclic Peptide Tyrosine Tyrosine Compounds As Modulators Of Neuropeptide Y Receptors App 20180117170 - Macielag; Mark ; et al.	2018-05-03
Kv1.3 Antagonists and Methods of Use App 20140255401 - Chi; Ellen ; et al.	2014-09-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.